Retractable Technologies, Inc. (NYSE:RVP) CEO Buys $14,360.58 in Stock

Retractable Technologies, Inc. (NYSE:RVP) CEO Thomas J. Shaw bought 18,411 shares of the stock in a transaction that occurred on Monday, January 6th. The stock was purchased at an average price of $0.78 per share, for a total transaction of $14,360.58. Following the completion of the purchase, the chief executive officer now directly owns 14,947,978 shares in the company, valued at $11,659,422.84. The trade was a 0.12 % increase in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link.

Retractable Technologies Price Performance

Shares of Retractable Technologies stock traded up $0.04 during midday trading on Tuesday, reaching $0.79. The company had a trading volume of 228,180 shares, compared to its average volume of 163,173. The company has a market capitalization of $23.65 million, a price-to-earnings ratio of -1.46 and a beta of 1.94. Retractable Technologies, Inc. has a 1-year low of $0.56 and a 1-year high of $1.34. The company has a current ratio of 8.57, a quick ratio of 5.92 and a debt-to-equity ratio of 0.01. The stock has a fifty day simple moving average of $0.66 and a 200 day simple moving average of $0.85.

Analyst Upgrades and Downgrades

Separately, StockNews.com began coverage on Retractable Technologies in a research report on Monday. They set a “hold” rating on the stock.

Hedge Funds Weigh In On Retractable Technologies

An institutional investor recently bought a new position in Retractable Technologies stock. PFG Investments LLC acquired a new position in shares of Retractable Technologies, Inc. (NYSE:RVP) in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor acquired 34,600 shares of the company’s stock, valued at approximately $27,000. PFG Investments LLC owned 0.12% of Retractable Technologies at the end of the most recent reporting period. Institutional investors and hedge funds own 7.58% of the company’s stock.

Retractable Technologies Company Profile

Retractable Technologies, Inc designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession in the United States, rest of North and South America, and internationally. The company offers VanishPoint insulin syringes; tuberculin, insulin, and allergy antigen syringes; small diameter tube adapters; blood collection tube holders; allergy trays; IV safety catheters; Patient Safe syringes and Luer Caps; VanishPoint blood collection sets; EasyPoint needles; and VanishPoint autodisable syringes.